Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.

Informacje na temat projektu

ETERNAL

Identyfikator umowy o grant: 101057668

DOI

10.3030/101057668

Data podpisania przez KE 23 Maja 2022

Data rozpoczęcia 1 Września 2022

Data zakończenia 31 Sierpnia 2026

Finansowanie w ramach

• Health

Koszt całkowity

€ 5 922 398,75

Wkład UE

€ 5 922 396,00

Koordynowany przez

AIMPLAS - ASOCIACION DE INVESTIGACION DE MATERIALES PLASTICOS Y CONEXAS
Spain

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Documents, reports (5)

Report on the standardization landscape and applicable standards

Report summarizing the relevant standardization landscape and appliable standards

Roadmap for adoption of PAT and Digital Twin Technologies (including regulatory compliance requirements)

Report that will consist in a summary review of SoA of PAT and Digital Twin adoption in European Pharmaceutical industry; a SWOT analysis to feed into an Opportunities Roadmap that also takes account of the regulatory hurdles, as well as recommendations for a favorable/enabling regulatory framework, without compromising safety.

"Concept paper on ""compliance-by-design"" key-drivers and roadmap of the possible regulatory pathways or relevant regulatory frameworks for the required ""compliance-by-design"" strategies"

Concept paper that reviews the latest developments in the scientific review, regulation, and marketing authorization procedures in the respective fields (related to the ETERNAL technological processes and developments) to inform a ‘compliant-by-design’ strategy in relation to the developments as part of the ETERNAL cocreation process.

Report on the contribution to standardization

Report outlining the contribution the project has/will make to standards.

Research roadmap and inventory of tools for the integration of existing knowledge into pharma risk assessment

Public report that documents a research roadmap for the integration of scientific and regulatory knowledge into pharmaceutical risk assessment for fate modelling, bioavailability assessment and receptor identification, for regulatory testing and assessment, and inventory of tools for the integration of existing knowledge into pharma risk assessment.

Websites, patent fillings, videos etc. (1)

Project website

Project website.

Publikacje

Peer reviewed articles (5)

A framework for early-stage sustainability assessment of innovation projects enabled by weighted sum multi-criteria decision analysis in the presence of uncertainty

Autorzy: John Henderson; Robert Peeling
Opublikowane w: Open Research Europe, 2024, ISSN 2732-5121
Wydawca: Open Research Europe
DOI: 10.12688/OPENRESEUROPE.18195.1

Recovery and reuse of homogeneous palladium catalysts <i>via</i> organic solvent nanofiltration: application in the synthesis of AZD4625

Autorzy: Hui Xiao; William R. F. Goundry; Rhys Griffiths; Yanyue Feng; Staffan Karlsson
Opublikowane w: Green Chemistry, 2025, ISSN 1463-9270
Wydawca: Royal Society of Chemistry (RSC)
DOI: 10.1039/D4GC06334A

Environmental Toxicology

Autorzy: Fábio Campos; Maria D. Pavlaki; Amadeu M. V. M. Soares; Susana Loureiro
Opublikowane w: Environmental Toxicology, 2025, ISSN 1520-4081
Wydawca: John Wiley & Sons Inc.
DOI: 10.1002/TOX.70002

Continuous improvement towards environmental protection for pharmaceuticals: advancing a strategy for Europe

Autorzy: Sam Harrison, Catherine Barnett, Stephen Short, Cansu Uluseker, Patricia V. Silva, Maria D. Pavlaki, Sarah Roberts, Madalena Vieira, Stephen Lofts, Susana Loureiro, David J. Spurgeon
Opublikowane w: Environmental Sciences Europe, Numer 37, 2025, ISSN 2190-4715
Wydawca: Springer Science and Business Media LLC
DOI: 10.1186/S12302-025-01180-Z

Organic Solvent Nanofiltration in Pharmaceutical Applications

Autorzy: Xiaoa, Hui; Feng, Yanyue; Goundry, William R.F.; Karlsson, Staffan
Opublikowane w: Organic Process Research and Development, 2024, ISSN 0000-0000
Wydawca: American Chemical Society
DOI: 10.1021/acs.oprd.3c00470

Conference proceedings (6)

Project Eternal Overview Presentation

Autorzy: Ferrer Pérez, Pablo; Sebastia-Luna, Paz; Henderson, John
Opublikowane w: 2025
Wydawca: ZENODO
DOI: 10.5281/ZENODO.10688671

Workshop Output report from an ETERNAL Industry engagement workshop at Making Pharmaceuticals UK Conference programme. Making Pharmaceuticals UK Conference, Coventry, United Kingdom.

Autorzy: Henderson, J.
Opublikowane w: Zenodo, 2024
Wydawca: Zenodo
DOI: 10.5281/ZENODO.12745018

SETAC_Pharmaceuticals Strategy for Europe A Call for Continuous Improvement towards Environmental Protection

Autorzy: Sam Harrison
Opublikowane w: SETAC Europe 34th Annual Meeting (SETAC), Seville, 2025
Wydawca: SPRINGER
DOI: 10.1186/s12302-025-01180-z

Assessing the feasibility of Twin Screw Extrusion processing in the development of pharmaceutical products

Autorzy: Ficiarà, E.
Opublikowane w: 2024
Wydawca: Zenodo
DOI: 10.5281/ZENODO.15114844

A New Collaboration to Establish Safe and Sustainable Pharmaceutical Lifecycles by Design

Autorzy: Henderson, John; Peeling Robert
Opublikowane w: 2025
DOI: 10.5281/zenodo.10788903

Optimized used of solvents in Active Pharmaceutical Ingredients production

Autorzy: Iacoangeli, T.
Opublikowane w: 2024
Wydawca: Zenodo
DOI: 10.5281/ZENODO.15114540

Other (1)

"Concept paper on ""compliant-by-design"" key-drivers and roadmap of the possible regulatory pathways or relevant regulatory frameworks for the required ""compliant-by-design"" strategies"

Autorzy: Diego Hernandez Pedraza
Opublikowane w: 2023
Wydawca: 00000
DOI: 10.5281/ZENODO.12795163